Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-pim-1 | 5 | 2014 | 45 | 1.300 |
Why?
|
| Pyridazines | 3 | 2013 | 306 | 0.680 |
Why?
|
| Polynucleotide Adenylyltransferase | 2 | 2009 | 13 | 0.590 |
Why?
|
| Imidazoles | 3 | 2013 | 1028 | 0.550 |
Why?
|
| 2-Chloroadenosine | 2 | 2009 | 37 | 0.540 |
Why?
|
| Deoxyadenosines | 2 | 2008 | 42 | 0.520 |
Why?
|
| Adenosine Triphosphate | 3 | 2012 | 578 | 0.520 |
Why?
|
| Adenosine | 3 | 2012 | 294 | 0.430 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 1937 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2013 | 1515 | 0.420 |
Why?
|
| ATP Synthetase Complexes | 1 | 2009 | 5 | 0.340 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2013 | 2425 | 0.340 |
Why?
|
| RNA, Neoplasm | 2 | 2009 | 797 | 0.320 |
Why?
|
| Antineoplastic Agents | 8 | 2014 | 14501 | 0.270 |
Why?
|
| Oligonucleotides | 2 | 2004 | 231 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2011 | 2547 | 0.240 |
Why?
|
| DNA Polymerase I | 1 | 2003 | 27 | 0.220 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2014 | 4884 | 0.200 |
Why?
|
| Multiple Myeloma | 2 | 2013 | 2235 | 0.180 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 620 | 0.180 |
Why?
|
| RNA | 2 | 2004 | 1030 | 0.180 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2011 | 284 | 0.160 |
Why?
|
| Apoptosis | 6 | 2013 | 7757 | 0.150 |
Why?
|
| Poly A | 2 | 2009 | 91 | 0.150 |
Why?
|
| Models, Chemical | 2 | 2009 | 187 | 0.140 |
Why?
|
| Lymphocytes | 2 | 2010 | 1237 | 0.120 |
Why?
|
| DNA Primers | 2 | 2009 | 1421 | 0.120 |
Why?
|
| DNA | 1 | 2003 | 2742 | 0.120 |
Why?
|
| Protein Conformation | 2 | 2009 | 1271 | 0.110 |
Why?
|
| Cell Survival | 4 | 2014 | 3061 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2011 | 7062 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2013 | 6221 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2011 | 4885 | 0.090 |
Why?
|
| Cell Death | 2 | 2013 | 675 | 0.090 |
Why?
|
| Halogenation | 1 | 2009 | 14 | 0.090 |
Why?
|
| Hydrolysis | 1 | 2009 | 231 | 0.080 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 902 | 0.080 |
Why?
|
| Deoxyadenine Nucleotides | 1 | 2008 | 24 | 0.080 |
Why?
|
| Cattle | 1 | 2009 | 790 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 396 | 0.080 |
Why?
|
| Receptors, Growth Factor | 1 | 2008 | 163 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 3148 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2011 | 1864 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 1637 | 0.070 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2012 | 1126 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 570 | 0.070 |
Why?
|
| Glycolysis | 1 | 2009 | 530 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 509 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 682 | 0.070 |
Why?
|
| Caspases | 1 | 2008 | 685 | 0.060 |
Why?
|
| Animals | 6 | 2014 | 60939 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2004 | 82 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2008 | 424 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2008 | 1798 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2009 | 1768 | 0.060 |
Why?
|
| Cell Division | 1 | 2008 | 2554 | 0.060 |
Why?
|
| Thymidine | 1 | 2003 | 151 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2004 | 559 | 0.060 |
Why?
|
| Gene Expression | 1 | 2011 | 3594 | 0.050 |
Why?
|
| Protein Binding | 1 | 2009 | 3480 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3930 | 0.050 |
Why?
|
| RNA, Complementary | 1 | 2002 | 9 | 0.050 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2002 | 35 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2002 | 116 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 629 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 3664 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 2098 | 0.050 |
Why?
|
| RNA Stability | 1 | 2002 | 136 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 539 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2002 | 283 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2002 | 539 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 5509 | 0.050 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 2585 | 0.040 |
Why?
|
| Inflammation | 1 | 2010 | 2567 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 2371 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 5028 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 590 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 14850 | 0.040 |
Why?
|
| Humans | 9 | 2014 | 270414 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2003 | 1220 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2010 | 2954 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3288 | 0.030 |
Why?
|
| Neoplasms | 2 | 2014 | 15698 | 0.030 |
Why?
|
| Mice | 2 | 2013 | 35282 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 342 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2010 | 12135 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 632 | 0.030 |
Why?
|
| K562 Cells | 1 | 2012 | 340 | 0.020 |
Why?
|
| Time Factors | 1 | 2004 | 13252 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2012 | 570 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2014 | 5292 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 2115 | 0.020 |
Why?
|
| Imatinib Mesylate | 1 | 2012 | 1687 | 0.020 |
Why?
|
| Drug Design | 1 | 2010 | 383 | 0.020 |
Why?
|
| Autophagy | 1 | 2013 | 930 | 0.020 |
Why?
|
| Benzamides | 1 | 2012 | 1873 | 0.020 |
Why?
|
| Piperazines | 1 | 2012 | 2130 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 5239 | 0.010 |
Why?
|
| Female | 1 | 2011 | 147052 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2012 | 3603 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2012 | 7300 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 9064 | 0.010 |
Why?
|
| United States | 1 | 2010 | 16302 | 0.010 |
Why?
|